Neuland Labs.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE794A01010
  • NSEID: NEULANDLAB
  • BSEID: 524558
INR
20,633.45
-459.15 (-2.18%)
BSENSE

Nov 20

BSE+NSE Vol: 38.44 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 229993,
    "name": "Neuland Labs.",
    "stock_name": "Neuland Labs.",
    "full_name": "Neuland Laboratories Ltd",
    "name_url": "stocks-analysis/neuland-labs",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "20,633.45",
    "chg": -459.15,
    "chgp": "-2.18%",
    "dir": -1,
    "prev_price": "21,092.60",
    "mcapval": "26,763.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 524558,
    "symbol": "NEULANDLAB",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE794A01010",
    "curr_date": "Nov 20",
    "curr_time": "",
    "bse_nse_vol": "38.44 k",
    "exc_status": "Active",
    "traded_date": "Nov 20, 2026",
    "traded_date_str": "2026 11 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/neuland-labs-229993-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Neuland Laboratories Ltd is Rated Hold by MarketsMOJO",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/neuland-laboratories-ltd-is-rated-hold-by-marketsmojo-4262537",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/NeulandLaborato_mojoScore_4262537.png",
        "date": "2026-11-15 10:10:05",
        "description": "Neuland Laboratories Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 04 Nov 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 15 November 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Neuland Laboratories’ Mixed Week: -0.02% Price Change Amid Technical Shifts and Financial Fluctuations",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/neuland-laboratories-mixed-week--002-price-change-amid-technical-shifts-and-financial-fluctuations-4256178",
        "imagepath": "",
        "date": "2026-11-08 13:00:08",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>Nov 2:</strong> Stock opens at Rs.19,576.05, down 0.63% despite Sensex rallying 1.57%</p>\n                    <p><strong>Nov 3:</strong> Further decline to Rs.19,435.20 (-0.72%) as technical concerns emerge</p>\n                    <p><strong>Nov 4:</strong> Mixed quarterly results announced; stock rebounds to Rs.19,614.30 (+0.92%)</p>\n                    <p><strong>Nov 5:</strong> Technical momentum shifts to mildly bullish; price rises to Rs.19,771.85 (+0.80%)</p>\n                    <p><strong>Nov 6:</strong> Slight pullback to Rs.19,696.75 (-0.38%) as week closes</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div ..."
      },
      {
        "title": "Neuland Laboratories Ltd Technical Momentum Shifts Signal Mildly Bullish Outlook",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/neuland-laboratories-ltd-technical-momentum-shifts-signal-mildly-bullish-outlook-4251198",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/NeulandLaborato_technicaldot_4251198.png",
        "date": "2026-11-05 08:01:00",
        "description": "Neuland Laboratories Ltd has exhibited a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. Recent technical indicators, including MACD, RSI, and moving averages, suggest a cautiously optimistic outlook for this pharmaceuticals and biotechnology small-cap, supported by a Mojo Grade upgrade from Sell to Hold."
      },
      {
        "title": "Neuland Laboratories Ltd Reports Mixed Quarterly Results Amid Positive Financial Trend",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/neuland-laboratories-ltd-reports-mixed-quarterly-results-amid-positive-financial-trend-4250712",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/NeulandLaborato_fintrenddot_4250712.png",
        "date": "2026-11-04 11:00:13",
        "description": "Neuland Laboratories Ltd has demonstrated a notable shift in its financial trajectory with a positive trend emerging in the latest half-year results, despite a challenging quarterly performance. The company’s recent figures reveal strong growth in profitability and operational efficiency over six months, contrasting with a decline in quarterly sales and earnings compared to the previous year’s averages."
      },
      {
        "title": "Neuland Laboratories Ltd Faces Technical Momentum Shift Amid Mixed Indicator Signals",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/neuland-laboratories-ltd-faces-technical-momentum-shift-amid-mixed-indicator-signals-4249752",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/NeulandLaborato_technicaldot_4249752.png",
        "date": "2026-11-04 08:01:05",
        "description": "Neuland Laboratories Ltd has experienced a notable shift in its technical momentum, transitioning from a mildly bullish stance to a sideways trend. This change is underscored by mixed signals from key technical indicators such as MACD, RSI, and moving averages, reflecting a complex market environment for the small-cap pharmaceutical player."
      },
      {
        "title": "Neuland Laboratories Ltd is Rated Buy",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/neuland-laboratories-ltd-is-rated-buy-4235149",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/NeulandLaborato_mojoScore_4235149.png",
        "date": "2026-10-23 10:10:33",
        "description": "Neuland Laboratories Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 October 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Neuland Laboratories Ltd is Rated Buy by MarketsMOJO",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/neuland-laboratories-ltd-is-rated-buy-by-marketsmojo-4222672",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/NeulandLaborato_mojoScore_4222672.png",
        "date": "2026-10-12 10:10:44",
        "description": "Neuland Laboratories Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics presented here reflect the stock’s current position as of 12 October 2026, providing investors with the most up-to-date insight into the company’s performance and outlook."
      },
      {
        "title": "Neuland Laboratories Ltd is Rated Buy",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/neuland-laboratories-ltd-is-rated-buy-4211065",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/NeulandLaborato_mojoScore_4211065.png",
        "date": "2026-10-01 10:10:47",
        "description": "Neuland Laboratories Ltd is rated Buy by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 01 October 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Neuland Laboratories Ltd Technical Momentum Shifts Signal Mildly Bullish Outlook",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/neuland-laboratories-ltd-technical-momentum-shifts-signal-mildly-bullish-outlook-4206686",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/NeulandLaborato_technicaldot_4206686.png",
        "date": "2026-09-28 08:00:46",
        "description": "Neuland Laboratories Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has recently experienced a subtle shift in its technical momentum, moving from a bullish to a mildly bullish stance. Despite a marginal day decline of 0.02%, the stock’s long-term performance remains robust, outpacing the Sensex significantly over multiple time horizons. This article analyses the latest technical indicators, price momentum, and what these signals imply for investors eyeing this stock."
      }
    ],
    "total": 88,
    "sid": "229993",
    "stock_news_url": "https://researchintel.adityabirlamoney.com/news/neuland-laboratories-229993"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "16-Nov-2026",
      "details": "Copy of Newspaper Publication",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "06-Nov-2026",
      "details": "Intimation about Schedule of Analyst / Institutional Investor Meeting on November 17 2026",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
      "datetime": "06-Nov-2026",
      "details": "Transcript of the Earnings Call conducted on November 3 2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Neuland Laboratories Ltd has declared <strong>340%</strong> dividend, ex-date: 24 Jul 26",
          "dt": "2026-07-24",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Neuland Laboratories Ltd has announced <strong>4:25</strong> rights issue, ex-date: 13 Aug 14",
          "dt": "2014-08-13",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Newspaper Publication

16-Nov-2026 | Source : BSE

Copy of Newspaper Publication

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

06-Nov-2026 | Source : BSE

Intimation about Schedule of Analyst / Institutional Investor Meeting on November 17 2026

Announcement under Regulation 30 (LODR)-Earnings Call Transcript

06-Nov-2026 | Source : BSE

Transcript of the Earnings Call conducted on November 3 2026

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Neuland Laboratories Ltd has declared 340% dividend, ex-date: 24 Jul 26

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

Neuland Laboratories Ltd has announced 4:25 rights issue, ex-date: 13 Aug 14